|
Monday 1st July 2024 |
Text too small? |
Cannasouth Limited (NZX: CBD ) announces that, following the Watershed Meeting on 7 June 2024, its subsidiaries, Cannasouth Cultivation Limited, Eqalis Pharmaceuticals Limited, Eqalis Innovations Limited, Eqalis Group New Zealand Limited and RestoreMe Clinic Limited (all subject to Deed of Company Arrangement) are parties to, and have executed, a Deed of Company Arrangement.
For further information visit www.cannasouth.co.nz or contact:
Garry Whimp
Administrator, Blacklock Rose Ltd
Email: gwhimp@blr.co.nz
Mobile: 021 587 230
Ben Francis
Administrator, Blacklock Rose Ltd
Email: bfrancis@blr.co.nz
Mobile: 021 042 6991
No comments yet
CHI - Channel Infrastructure delivers solid FY25 financial result
February 27th Morning Report
TRU - Results Guidance FY2026
TRU - Results Guidance FY2026
MEE - Me Today announces six-month results to 31 December 2025
HGH - Heartland announces 1H2026 result
BRW - FY26 Half Year Results Announcement
February 25th Morning Report
Genesis completes NZ$100m Placement
MCY - Invests heavily in renewables; delivers strong performance